Amethyst Radiothérapie France is a private group of cancer treatment centers in France, with a network of 5 centers that utilize the latest technologies and advanced techniques in radiotherapy and brachytherapy.
The group, founded in 2010, has rapidly expanded, and currently, more than 3000 patients are treated annually across its centers by a workforce of approximately 100 collaborators. The company emphasizes the combination of extensive cancer expertise with state-of-the-art techniques to provide world-class treatment to its patients. This is made possible through the use of high-tech equipment that is regularly updated.
With a focus on continuous improvement, Amethyst radiothérapie has garnered support from renowned experts in cancer treatment such as Pr. J-M Cosset and Dr. Christine Haie Meder who provide assistance to the medical teams. The company has also received investment from The Rohatyn Group in a Private Equity Round in November 2019.
As of now, the company has built, acquired, and managed a total of ten cancer treatment centers and is rapidly expanding its presence across Europe. Operating within the Health Care industry, Amethyst Radiothérapie France remains committed to leveraging its expertise and cutting-edge technology to deliver effective cancer treatment.
No recent news or press coverage available for Amethyst Radiotherapy Group.